Meska Joinway Pharmaceutical Co., Ltd. is a high-tech enterprise under Meska Group, mainly engaged in the production and operation of new pharmaceutical excipients and various types of industrial cellulose ethers. Joinway Pharma attaches great importance to product development and technical cooperation, and has established an industry-university-research linkage platform with well-known domestic colleges and universities such as Tsinghua University, Peking University, and Zhejiang University. The company currently has 260 employees, including 16 professors, 8 senior engineers, 23 engineers, and 26 technical developers. More than 20% of all employees are professional and technical personnel directly engaged in the scientific research and development of new products, initially forming a research and development and production base for new pharmaceutical excipients, pharmaceutical intermediates, preparations and various types of industrial cellulose ethers. We always adhere to the principle of "customer first, quality first", relying on advanced management, strong technical force, and a complete quality management system to meet the needs of downstream users in the pharmaceutical and chemical industry chain.

At present, Joinway Pharma mainly produces new pharmaceutical excipients and various industrial cellulose ethers, such as hydroxypropyl methylcellulose, hydroxypropyl cellulose, microcrystalline cellulose, ethyl cellulose, micropowder silica gel, pregelatinized starch, sodium carboxymethyl starch, polyacrylic acid resin, magnesium stearate and other products. The product quality is at the leading level in China, and 8 of its products are listed as high-tech products. Micropowder silica gel products are listed as small and medium-sized technology innovation fund projects and national torch projects by the Ministry of Science and Technology. The products are sold at home and abroad and have been unanimously recognized by customers.

Faced with fierce market competition, Joinway Pharma is based on the health industry, takes science and technology as the guide, and strives to build five major platforms: scientific research and development, technological innovation, production management, capital operation, and marketing. It continuously strengthens its competitive advantages and is committed to developing into the best domestic and foreign supplier of pharmaceutical excipients, pharmaceutical intermediates, pharmaceutical preparations and various industrial cellulose ethers.